InnoCan Pharma's total assets for Q3 2025 were $15.47M, an increase of 40.15% from the previous quarter. TSE:INNO total liabilities were $4.49M for the fiscal quarter, a 3.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.